AGP Executive Report
Last update: 7 hours agoPatient Access: South African medical cannabis patients warn a reported freeze on new Section 21 approvals could leave people with epilepsy and severe neurological conditions without legal access to treatment. Medical Research: India’s CSIR-IIIM Jammu project is exploring cannabis-based medicines for pain, cancer, epilepsy and other conditions, with export-quality products as a goal. Hemp Rules: Illinois’ new rules require hemp-derived THC products above the federal potency threshold to be sold through licensed cannabis dispensaries and taxed like cannabis, unsettling Chicago businesses. Health Risks: A multinational study of 800 patients linked active cannabis use to higher mortality among people hospitalized with alcohol-associated hepatitis; researchers say substance-use care should be part of treatment. CBD Regulation: The EU’s top court has ruled that CBD foods cannot be labeled organic without authorization.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
